Aptorum Group Limited Form 6-K Filing

This filing is an amendment to Aptorum Group Limited's Form 6-K, disclosing information about a merger agreement with DiamiR Biosciences Corp. The merger involves Aptorum forming a subsidiary to merge with DiamiR, with DiamiR surviving as a subsidiary of Aptorum. The closing of the merger is subject to shareholder approval and other conditions. The filing includes pre-effective amendment no. 2 to the company's proxy statement/prospectus on Form S-4, which contains financial statements for both companies and related to the merger. This Form 6-K is incorporated by reference into Aptorum's registration statements on Form S-8 and Form F-3. The document also includes forward-looking statements regarding the company's future performance and business strategy, subject to risks and uncertainties. The filing lists various exhibits, including the merger agreement, an amendment to a management services agreement, consents from accounting firms, and XBRL documents.